Benjamin Yerxa is the current CEO of Opus Genetics. He previously worked at Atsena Therapeutics as a Board Member. Benjamin Yerxa attended the University of California, San Diego.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Foundation Fighting Blindness | CEO | Oct 1, 2017 | — | Detail |
Retinal Degeneration Fund | CEO | — | — | Detail |